CARDIODIGITAL

CardioDigital, Ltd. engages in the research and development of time-frequency-based analysis methods for medical signal analysis, monitoring, and prediction. The company's products include COP, a metric for cardioversion outcome prediction to aid in the clinical decision making process; PlethRESP, which enables the detection of respiration directly from the pleth waveform; and NovoSAT for the derivation of oxygen saturation measurement in wavelet space. It also offers consultancy services for individual companies. The company was founded in 2000 and is based in Elvingston, United Kingdom. As of August 7, 2008, CardioDigital, Ltd. operates as a subsidiary of Covidien, Ltd.